Drug and Device Companies Face New Federal Disclosure of Physician Payments

Quantity Discounts
1 - 9999
1 - 9999
1 - 9999
In this 90-minute Encore presentation, attorney John Oroho will provide clear guidance on what aspects of the law you’ll need to focus on and how to ensure compliance with them.

Sign up your entire team to listen in and discover:

  • The proposed Senate bill, S. 2029, and its potential effects on the industry
  • The specific impacts the medical device industry will now face for the first time
  • Six tips for complying with the proposed federal law
  • Current state reporting requirements in light of the federal legislation

You’ll learn how the new law affects you, the practical meaning of its various provisions and strategies for compliance with them. Register now and you'll get an opportunity to ask your toughest questions during the Q&A session.

This presentation is a must for employees of drug, biotech and medical device firms responsible for being current on the law, including:

  • Compliance officers
  • Sales and marketing professionals
  • Medical affairs specialists
  • General/corporate counsel
  • Regulatory/legislative affairs professionals

John Patrick Oroho, executive vice president of Porzio Pharmaceutical Services, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their understanding of acceptable practices and conduct in meeting compliance requirements of all 50 states and the District of Columbia.

Mr. Oroho is also a principal of Porzio, Bromberg & Newman in the pharmaceutical marketing and sales compliance and litigation department. His practice is concentrated in the areas of regulatory compliance and litigation with respect to the Prescription Drug Marketing Act, the anti-kickback statute, the False Claim Act, and Medicare and Medicaid fraud and abuse. Mr. Oroho previously served as senior vice president and general counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance.

Register now!

Date: July 21 – Aug. 8, 2008
Location: Your office or conference room (no need to travel!)
Time: Anytime

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Registrations may not be cancelled. Please contact customer service to make any substitutions.